News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
- Latest Posts
News and Trends 24 Mar 2025
First-ever RIPTAC enters clinic: all you need to know about this new cancer approach
The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.
News and Trends 21 Mar 2025
Depression drug trials are failing—and placebos are to blame
In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.
Podcast 21 Mar 2025
Are mitochondrial therapeutics about to go mainstream?
Listen to our talk with Klaus Dugi, CEO of Vandria, about mitochondrial therapeutics and longevity
Interview 20 Mar 2025
AI meets biotech: Bullfrog AI’s CEO on the TechBio boom
Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO.
In Depth 19 Mar 2025
Breast cancer treatments heat up: Five therapies poised to transform patient outcomes
Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field.
In Depth 17 Mar 2025
How biotechs are using AI to rescue failed drugs
Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.
In Depth 14 Mar 2025
Can GLP-1 agonists help treat addiction?
Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.
Podcast 14 Mar 2025
Fighting Alzheimer’s with innovative stem cell therapies
This week, we talk with Christopher Duma about his career in neurosurgery, the impetus for launching his biotech, and the promise of stem cell therapy in Alzheimer’s.
Best in Biotech 13 Mar 2025
Nine biotechs thriving in Seattle in 2025
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
ADVERTISEMENT
